NTRK2 and early-onset autosomal dominant Alzheimer disease: In line with our results, there is an emerging line of research that supports the role of the cognitive reserve and the BDNF/TrkB signaling pathway as compensatory responses that delay symptomatology in the early stage of Alzheimer's disease but cannot prevent neurodegeneration in more advanced phases16,80–82.